Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.

Saved in:
Bibliographic Details
Title: Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
Authors: Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, Weinberg GA, Selvarangan R, Boom JA, Klein EJ, Halasa NB, Ginde AA, Gibbs KW, Zhu Y, Self WH, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Weber ZA, Yang DH, Ball SW, Surie D, DeCuir J, Dawood FS, Moline HL, Toepfer AP, Clopper BR, Link-Gelles R, Payne AB, Chung JR, Flannery B, Lewis NM, Olson SM, Adams K, Tenforde MW, Garg S, Grohskopf LA, Reed C, Ellington S
Corporate Authors: CDC Influenza Vaccine Effectiveness Collaborators
Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 Feb 29; Vol. 73 (8), pp. 168-174. Date of Electronic Publication: 2024 Feb 29.
Publication Type: Journal Article
Journal Info: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1545-861X
DOI:10.15585/mmwr.mm7308a3